Home› Europe› EEA Joint Committee› Decision of the EEA Joint Committee No 111/2021 of 19 March ...
Date: 18-Jan-2024 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 111/2021 of 19 March 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/120]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • EEA Joint Committee Decision No 111/2021 amends Annex II to the EEA Agreement to incorporate Commission Implementing Regulation (EU) 2020/1086, which approves icaridin as an active substance for use in biocidal products of product-type 19.

Key Changes

  • The decision inserts point 12zzzzzzp into Chapter XV of Annex II of the EEA Agreement, referencing Commission Implementing Regulation (EU) 2020/1086.
  • Commission Implementing Regulation (EU) 2020/1086 approves icaridin as an existing active substance for use in biocidal products of product-type 19.
  • The authentic texts of Implementing Regulation (EU) 2020/1086 in Icelandic and Norwegian languages will be published in the EEA Supplement to the Official Journal of the European Union.
  • The decision entered into force on 20 March 2021, provided all notifications under Article 103(1) of the EEA Agreement were made.

Impact Analysis

Biocidal Product Manufacturers and Distributors

  • Ensure compliance with all relevant regulations and guidelines related to the use of icaridin in biocidal products.

Consumers

  • Consumers should follow the instructions and safety precautions provided on the product labels.

EEA Member States

  • National authorities responsible for biocidal product regulation should be aware of the inclusion of icaridin as an approved active substance.

Key Entities Referenced

EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement. EEA Agreement: The Agreement on the European Economic Area, which extends the EU's internal market to Iceland, Liechtenstein, and Norway. Commission Implementing Regulation (EU) 2020/1086: A regulation approving icaridin as an existing active substance for use in biocidal products of product-type 19. Icaridin: An active substance used in biocidal products, now approved for use in product-type 19 within the EEA. Product-type 19 Biocidal Products: Refers to a specific category of biocidal products as defined by relevant EU regulations.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2024/120 18.1.2024 DECISION OF THE EEA JOINT COMMITTEE No 111/2021 of 19 March 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/120] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Regulation (EU) 2020/1086 of 23 July 2020 approving icaridin as an existing active substance for use in biocidal products of product-type 19(1)is to be incorporated into the EEA Agreement. (2) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 The following point is inserted after point 12zzzzzzo (Commission Implementing Decision (EU) 2020/1038) of Chapter XV of Annex II to the EEA Agreement: ‘12zzzzzzp. 32020 R 1086: Commission Implementing Regulation (EU) 2020/1086 of 23 July 2020approving icaridin as an existing active substance for use in biocidal products of product-type 19 (OJ L 239, 24.7.2020, p. 9).’ Article 2 The text of Implementing Regulation (EU) 2020/1086 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. Article 3 This Decision shall enter into force on 20 March 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made*. Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 19 March 2021. For the EEA Joint Committee The President Clara GANSLANDT (1) OJ L 239, 24.7.2020, p. 9. * No constitutional requirements indicated. ELI: http://data.europa.eu/eli/dec/2024/120/oj 1/1

Continue your research

Related Documents from EEA Joint Committee